Research and development activities are the heart of the pharmaceutical industry’s value creation. R&D fuels the product pipeline but takes its fair share of the expense side of the balance sheet. It is estimated that bringing a successful drug to market from discovery through development to market launch costs well in excess of US$1 billion.
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize.
The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
All reports in Research & Development
|
541711 Research and Development In Biotechnology: State Industry Market Evaluator
6/1/2012 | published by: BizMiner
... industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, establishments, small business, startups). startup ...
|
more...
|
$699.00
|
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
... target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the ...
|
more...
|
$3,995.00
|
|
Biotechnology and Pharmaceuticals Report
4/30/2012 | published by: Wall Street Transcript
... interviews with 3 leading Analysts; and top management from 2 Sector Firms. Topics covered: Biotech Stocks Outperformance and Rally - FDA Drug Approval Process - M&A Activity Acceleration in 2012 - U.S. Health Care Regulation ...
|
more...
|
$175.00
|
|
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders
4/12/2012 | published by: GlobalData
... blood disorders such as beta-thalassemia and sickle cell anemia. An international team of researchers led by scientists at Weill-Cornell Medical College in New York City have designed a novel gene therapy strategy with potentially curative ...
|
more...
|
$500.00
|
|
Global Biotechnology
4/4/2012 | published by: IBISWorld
... products and services. The definition of biotechnology as used by the US Census Bureau and the National Science Foundation is the application of molecular and cellular processes to solve problems, conduct research, and create goods ...
|
more...
|
$935.00
|
|
Mesenchymal Stem Cells - Advances & Applications
4/1/2012 | published by: BioInformant Worldwide, L.L.C.
... most interest is that this rate of growth accelerated in 2011, making mesenchymal stem cells the fastest growing area of stem cell research. Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into ...
|
more...
|
$3,995.00
|
|
Global Protein Therapeutics Market Forecast to 2015
4/1/2012 | published by: RNCOS
... from cancer to metabolic disorders. Despite the post-recessionary impact worldwide causing major slump in the healthcare spending, the protein therapeutics market continued to grow at its retained speed. According to our report, the market still ...
|
more...
|
$2,000.00
|
|
Fragment-Based Drug Discovery: Technologies, Applications, and Pipelines - Overview
4/1/2012 | published by: CHI Insight Pharma Reports
... Drug Discovery: Technologies, Applications, and Pipelines, examines the many issues that must be considered vis-à-vis employment of fragment-based screening approaches. Chemical considerations are examined, including the impact of high-throughput screening (HTS) and its attendant shortcomings, ...
|
more...
|
$795.00
|
|
Strategic Analysis of the U.S. Research Antibodies Market
3/30/2012 | published by: Frost & Sullivan
... detection and quantification of particular targets within a sample. Provided within the study is a detailed history and market overview, important market metrics, key market drivers and restraints, and an analysis on competitive dynamics and ...
|
more...
|
$6,000.00
|
|
Biotechnology in the US - Industry Market Research Report
3/26/2012 | published by: IBISWorld
... reform, environmental concerns and the increasingly aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, causing research and development to increase over the period. ...
|
more...
|
$910.00
|
|
Scientific Research & Development in the US - Industry Market Research Report
3/21/2012 | published by: IBISWorld
... shifting funding sources have changed the type of research being performed. Historically, government money has been devoted mostly to basic research, meaning research without a specific goal. On the other hand, private and corporate money ...
|
more...
|
$910.00
|
|
Hematological Cancer Therapies
3/1/2012 | published by: CHI Insight Pharma Reports
... well as challenges and opportunities for pharmaceutical companies. This report discusses: The different types of hematological cancers, including information about the specific disease, its epidemiology, subtypes and/or staging if appropriate, current therapies, and patient prognosis. ...
|
more...
|
$2,495.00
|
|
Cancer Monoclonal Antibodies Market to 2015
3/1/2012 | published by: RNCOS
... years. In order to treat the life-threatening disease more efficiently and with enhanced specificity, monoclonal antibodies have become the most widely used cancer therapy. As per the findings of our new research report, cancer monoclonal ...
|
more...
|
$1,500.00
|
|
Worldwide Biotech - March 2012
3/1/2012 | published by: Worldwide Videotex
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.
|
more...
|
$25.00
|
|
Biotech Business - March 2012
3/1/2012 | published by: Worldwide Videotex
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline.
|
more...
|
$25.00
|
|
Biologicals in Oncology Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
... cancer. In addition, there are 17 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 676 drugs. Biologicals In Oncology Drug Pipeline Update lists all drugs and gives ...
|
more...
|
$3,749.00
|
|
Conference Documentation: Advances and Progress in Drug Design
2/21/2012 | published by: SMI Publishing, Ltd
... companies, pharmaceutical companies have never been under greater pressure to develop new innovative drugs. Many pharmaceutical and biotechnology companies are now searching for effective strategies to improve hit-to-lead conversion and to identify unsuccessful compounds early ...
|
more...
|
$800.00
|
|
Biotechnology in the UK - Industry Market Research Report
2/14/2012 | published by: IBISWorld
... the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their ...
|
more...
|
$865.00
|
|
Immunomodulators Market to 2017 - Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017
2/1/2012 | published by: GBI Research
... Immunosuppressant Antibodies to Replace Antimetabolites as the Highest Value Sector by 2017", which provides insight about immunomodulators sales forecasts until 2017.I Immunomodulators markets in the key geographies of the US, Europe and other relevant regions ...
|
more...
|
$3,500.00
|
|
Pharmacogenomics Partnering Terms and Agreements
2/1/2012 | published by: Current Partnering
... analysis of how and why companies enter pharmacogenomic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pharmacogenomic technology. ...
|
more...
|
$2,695.00
|
|
Biotechnology in the US - Industry Risk Rating Report
1/22/2012 | published by: IBISWorld
... report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising from the expected ...
|
more...
|
$910.00
|
|
Scientific Research & Development in the US - Industry Risk Rating Report
1/22/2012 | published by: IBISWorld
... operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks arising ...
|
more...
|
$910.00
|
|
Scientific Research in Australia - Industry Risk Rating Report
1/20/2012 | published by: IBISWorld
... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ...
|
more...
|
$990.00
|
|
Biotechnology in Australia - Industry Risk Rating Report
1/20/2012 | published by: IBISWorld
... business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), risks ...
|
more...
|
$990.00
|
|
Global Pharmaceuticals, Biotechnology & Life Sciences
1/17/2012 | published by: MarketLine
... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Global pharmaceuticals, biotechnology & life sciences market. Includes market size and segmentation ...
|
more...
|
$250.00
|
